It's an article in a German magazine (in english) which details the early history of Tamiflu (GS4104) as it struggled to compete with Biota and ultimately trumped, obviously not the sentiment I would have used,none the less there is enough detail comparing the Biota method with the short cuts and greed which Gilead needed to beat Biota in the antiviral market.
